matter.farm

Computer-generated molecule database for public drug discovery. About this project.

These compounds may interact with:

Egl nine homolog 1

Potentially involved in: primary polycythemia; carcinoma; polycythemia; persistent generalized lymphadenopathy; cancer; vascular disease; anemia; hematocrit increased; hemoglobin increased; erythrocytosis, familial, 3; increased red blood cell mass; acute quadriplegic myopathy; adult high grade glioma; atypical teratoid / rhabdoid tumor; fascioscapulohumeral muscular dystrophy; glioblastoma; lung cancer; medulloblastoma, large-cell; non-small cell lung cancer; osteosarcoma

Disease data sourced from Pharos.

Inhibitor